Results 151 to 160 of about 11,053 (191)

Knowledge, Attitudes, and Practices Regarding Herpes Zoster and Its Vaccine Among Primary Health Care Attendees in the United Arab Emirates: A Cross-Sectional Study. [PDF]

Cureus
Almeleh FA, Al Hayayi S, Alsalami A.
europepmc   +1 more source

Disseminated herpes zoster in adults: a single-center retrospective study on clinical spectrum and risk factors for adverse outcomes. [PDF]

Front Med (Lausanne)
Cai JL, Fan JG, Yi AR.
europepmc   +1 more source

The efficacy, immunogenicity and safety of a recombinant tetrameric gE-Fc fusion protein vaccine for herpes zoster in adults 40 years of age or older：a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Li J, Jin P, Quan Y, Gao X, Wei M, Cao X, Pan H, Shen H, Zhao L, Xu Q, Wang Z, Liu X, Xu J, Xu K, Wan W, Tong Y, Li Z, Xu S.   +17 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Zoster Vaccine Live

Pharmacotherapy, 2007
Herpes zoster is a neurocutaneous disease caused by the varicella‐zoster virus and is associated with significant morbidity and long‐term sequelae in older adults. Until recently, treatment options for these complications have been primarily targeted at disease state management and symptom relief.
Denise R Kockler, Michelle W Mccarthy
exaly   +3 more sources

Zoster Vaccine Live (Oka/Merck)

Drugs & Aging, 2006
A subcutaneously administered, live, high-titre (18,700-60,000 plaque-forming units per dose) varicella zoster virus (VZV) vaccine (zoster vaccine) of the Oka/Merck strain has been evaluated for the prevention of herpes zoster and the reduction of zoster-associated pain in adults aged > or =60 years.
Dean M, Robinson, Caroline M, Perry
openaire   +3 more sources

Live Attenuated Varicella-Zoster Vaccine

Clinical Infectious Diseases, 1980
Varicella-zoster (VZ) virus causes two diseases, varicella and zoster. Because it was recognized that, after varicella, latent VZ virus persisted in the host and because varicella was thought to be a milde disease, there was little impetus in North America to develop a live VZ vaccine.
openaire   +2 more sources

Varicella zoster virus vaccine live

Reactions Weekly, 2017
  +8 more sources

Varicella zoster virus vaccine live

Reactions Weekly, 2008
  +8 more sources